Answers are grounded in this paper and cite their sources.
Findings reveal circTMEM45A activates NLRP3 through m5C modifications in esophageal carcinoma, suggesting inflammatory pathways contribute to cancer progression.
Supplementary Figure 7. Prediction of m5C modification sites of circTMEM45A and NLRP3. (A) StarBase predicts the binding potential of circTMEM45A to miRNAs. (B) RNAm5Cfinder predicts m5C modifications in circTMEM45A. (C-D) m5C Atlas and RMDisease predict m5C modifications in NLRP3. (E-F) RIP assay demonstrating the enrichment of circTMEM45A (E) and NLRP3 (F) by m5C antibody in KYSE150 cells. ns: not significant, ***P<0.001.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: